Please login to the form below

BioMarin

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of BioMarin's 2012 metabolic sales performance.

BioMarin eyes 2019 FDA filing for haemophilia A gene therapy

BioMarin eyes 2019 FDA filing for haemophilia A gene therapy. Valrox study revealed a 97% reduction in mean annual bleed rates. ... our development and accelerated regulatory strategy, ”said BioMarin’s chief executive Hank Fuchs.

Bayer roll-out of haemophilia drug Jivi gathers pace

BioMarin and Spark Therapeutics.

Daily Brief: Jazz Pharma and Ultragenyx approvals, Autonomous AI in retinopathy

Another variant of the disease, MPS IVa already has a treatment available – Biomarin’s Vimizim.

Spark sputters on haemophilia A gene therapy safety scare

Spark sputters on haemophilia A gene therapy safety scare. Investors compare data unfavourably with BioMarin rival. ... meeting the factor threshold because of reactions – suggesting that could affect SPK-8011’s competitive profile compared to other

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 (Next 4)

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Featured jobs

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Production Manager – Healthcare Communications: DOE

Medical Writers: Competitive Salary and Benefits

Account Manager / Account Director: Competative

Client Services Director – Medical Education Agency – North West...: Salary TBC

Events Manager – Med Comms – Surrey: Salary TBC

Consultant Health Economics - London / Oxford: Negotiable

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Senior Medical Writer (Remote Working): Competitive Salary Offered

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Senior Medical Writer: Great salary and benefits

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Account Manager / Senior Account Manager: 35, 000-40, 000

Senior Account Executive, London, Medical Communications: Excellent package

Project / Account Manager (Medical Education): Salary TBC

Senior Systematic Review Analyst - Oxford: Negotiable

Account Director: Excellent benefits

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...